查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1703390

吻合器市場－全球產業規模、佔有率、趨勢、機會和預測（按產品、應用、最終用途、地區和競爭細分，2020-2030 年）

Anastomosis Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End-use, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球吻合器市場價值為 36 億美元，預計在預測期內將呈現穩定成長，到 2030 年的年複合成長率(CAGR) 為 5.28%。

市場概覽
預測期 2026-2030
2024年市場規模 36億美元
2030年市場規模 49.1億美元
2025-2030 年複合年成長率 5.28%
成長最快的領域 一次性的
最大的市場 北美洲

近年來，醫療器材領域的技術進步顯著，吻合器材的開發取得了顯著進展。這些裝置在外科手術過程中至關重要，可以連接兩個血管或空心器官（例如腸道或輸尿管），以恢復正常的生理功能。吻合裝置已成為心血管、胃腸道和泌尿外科等多種外科專業中不可或缺的一部分。

受慢性病發病率上升、全球人口老化以及外科技術進步等因素推動，市場成長持續強勁。這些設備對於旁路移植、腸切除和器官移植等手術至關重要，這些手術正變得越來越頻繁。

關鍵市場促進因素

外科手術數量不斷增加

主要市場挑戰

監理複雜性

主要市場趨勢

技術創新

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：吻合器市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按產品（一次性、可重複使用）
    • 依應用（心血管外科、胃腸外科、其他）
    • 依最終用途（醫院、門診護理中心和診所）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美吻合器市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲吻合器市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章：亞太吻合器械市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美吻合器市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲吻合器市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章：全球吻合器市場：SWOT 分析

第 14 章：競爭格局

  • Medtronic plc
  • LivaNova PLC
  • MAQUET Holding BV & Co. KG.
  • Dextera Surgical Inc.
  • Vitalitec Internaional Inc.
  • Synovis Micro Companies Alliance, Inc.
  • Ethicon US, LLC
  • Peters Surgical SASU

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16735

Global Anastomosis devices market was valued at USD 3.60 billion in 2024 and is projected to exhibit steady growth over the forecast period, with a compound annual growth rate (CAGR) of 5.28% through 2030.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.60 Billion
Market Size 2030USD 4.91 Billion
CAGR 2025-20305.28%
Fastest Growing SegmentDisposable
Largest MarketNorth America

The medical devices sector has experienced significant technological advancements in recent years, with notable progress in the development of anastomosis devices. These devices are essential in surgical procedures, enabling the connection of two blood vessels or hollow organs-such as the intestines or ureters-to restore normal physiological function. Anastomosis devices have become indispensable in a variety of surgical specialties, including cardiovascular, gastrointestinal, and urological procedures.

Market growth has been consistently strong, driven by factors such as the increasing prevalence of chronic diseases, an aging global population, and advancements in surgical techniques. These devices are critical in procedures such as bypass grafting, bowel resections, and organ transplantation, all of which are becoming more frequent.

Key Market Drivers

Rising Number of Surgical Procedures

The increasing volume of surgical procedures globally is a primary factor fueling the growth of the anastomosis devices market. It is estimated that between 220 and 344 million surgeries are performed worldwide annually, with high-frequency operations such as cataract removals, cesarean deliveries, and orthopedic joint replacements accounting for a significant portion. Despite this, disparities in access to safe, timely, and affordable surgical care persist-particularly in low- and middle-income countries-posing a barrier to healthcare equity and system development.

Anastomosis devices are integral in surgeries requiring the connection of blood vessels, gastrointestinal structures, or other tubular systems. As the global demand for surgical interventions increases, so does the need for reliable, efficient, and minimally invasive anastomosis solutions.

Each year, an estimated two million patients undergo open-heart surgery to treat conditions such as coronary artery disease, valvular abnormalities, and congenital heart defects. These complex procedures often require precise vascular connections, driving the demand for high-performance anastomosis devices.

Furthermore, the global rise in chronic diseases-such as cardiovascular disorders, cancer, gastrointestinal conditions, and obesity-has led to a growing need for surgical interventions including CABG, colorectal surgery, and bariatric procedures. These often involve anastomosis and underscore the increasing preference for advanced devices that reduce operation times, minimize complications, and enhance patient outcomes. This sustained demand continues to support market growth.

Key Market Challenges

Regulatory Complexity

A major challenge for the anastomosis devices market is navigating stringent regulatory approval processes. Authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) enforce rigorous standards regarding the safety and efficacy of medical devices. Compliance with these requirements can be both time-intensive and costly, often resulting in delays to product launches and increased development expenditures for manufacturers.

Key Market Trends

Technological Innovation

Technological advancements are playing a transformative role in the anastomosis devices market, significantly enhancing surgical precision and patient outcomes. The field has witnessed major innovations that have simplified procedures and improved recovery times.

The adoption of minimally invasive surgical techniques, including robotic-assisted and laparoscopic systems, has improved the accuracy and reduced the invasiveness of complex anastomosis procedures. High-resolution visualization technologies-such as 3D imaging, augmented reality, and intraoperative imaging systems-enable surgeons to perform more precise operations with real-time feedback.

Innovations in biomaterials and tissue engineering are also reshaping the market. New materials that promote tissue regeneration and healing-such as bio-absorbable staples and tissue adhesives-are reducing post-operative risks. Advanced surgical staplers now feature adjustable staple heights, tissue-sensing capabilities, and real-time feedback systems to ensure optimal performance.

Electrosurgical devices are becoming increasingly popular for their precision and ability to minimize bleeding during tissue dissection and coagulation, leading to reduced post-surgical complications.

Key Market Players

  • Medtronic plc
  • LivaNova PLC
  • MAQUET Holding B.V. & Co. KG.
  • Dextera Surgical Inc.
  • Vitalitec Internaional Inc.
  • Synovis Micro Companies Alliance, Inc.
  • Ethicon US, LLC
  • Peters Surgical SASU

Report Scope:

In this report, the Global Anastomosis Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anastomosis Devices Market, By Product:

  • Disposable
  • Reusable

Anastomosis Devices Market, By Application:

  • Cardiovascular Surgery
  • Gastrointestinal Surgery
  • Others

Anastomosis Devices Market, By End-Use:

  • Hospitals
  • Ambulatory Care Centres & Clinics

Anastomosis Devices Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Anastomosis Devices Market.

Available Customizations:

Global Anastomosis Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Anastomosis Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Disposable, Reusable)
    • 5.2.2. By Application (Cardiovascular Surgery, Gastrointestinal Surgery, Others)
    • 5.2.3. By End-Use (Hospitals, Ambulatory Care Centers & Clinics)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Anastomosis Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End-Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Anastomosis Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-Use
    • 6.3.2. Canada Anastomosis Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-Use
    • 6.3.3. Mexico Anastomosis Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-Use

7. Europe Anastomosis Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End-Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Anastomosis Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-Use
    • 7.3.2. United Kingdom Anastomosis Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-Use
    • 7.3.3. Italy Anastomosis Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-Use
    • 7.3.4. France Anastomosis Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-Use
    • 7.3.5. Spain Anastomosis Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-Use

8. Asia-Pacific Anastomosis Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End-Use
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Anastomosis Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-Use
    • 8.3.2. India Anastomosis Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-Use
    • 8.3.3. Japan Anastomosis Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-Use
    • 8.3.4. South Korea Anastomosis Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-Use
    • 8.3.5. Australia Anastomosis Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-Use

9. South America Anastomosis Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End-Use
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Anastomosis Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-Use
    • 9.3.2. Argentina Anastomosis Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-Use
    • 9.3.3. Colombia Anastomosis Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-Use

10. Middle East and Africa Anastomosis Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End-Use
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Anastomosis Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-Use
    • 10.3.2. Saudi Arabia Anastomosis Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-Use
    • 10.3.3. UAE Anastomosis Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Anastomosis Devices Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Medtronic plc
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. LivaNova PLC
  • 14.3. MAQUET Holding B.V. & Co. KG.
  • 14.4. Dextera Surgical Inc.
  • 14.5. Vitalitec Internaional Inc.
  • 14.6. Synovis Micro Companies Alliance, Inc.
  • 14.7. Ethicon US, LLC
  • 14.8. Peters Surgical SASU

15. Strategic Recommendations

16. About Us & Disclaimer